ATE173626T1 - Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis - Google Patents
Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitisInfo
- Publication number
- ATE173626T1 ATE173626T1 AT95112104T AT95112104T ATE173626T1 AT E173626 T1 ATE173626 T1 AT E173626T1 AT 95112104 T AT95112104 T AT 95112104T AT 95112104 T AT95112104 T AT 95112104T AT E173626 T1 ATE173626 T1 AT E173626T1
- Authority
- AT
- Austria
- Prior art keywords
- pancreatitis
- treatment
- producing
- medicinal product
- tocopheryl phosphate
- Prior art date
Links
- 206010033645 Pancreatitis Diseases 0.000 title abstract 3
- IOZWJJBOYMUHEJ-HMQIKIGCSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] hydrogen phosphate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OP(O)(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O IOZWJJBOYMUHEJ-HMQIKIGCSA-N 0.000 title 1
- 229940115445 ascorbyl tocopheryl phosphate Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- -1 diester compound Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18428294 | 1994-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE173626T1 true ATE173626T1 (de) | 1998-12-15 |
Family
ID=16150598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95112104T ATE173626T1 (de) | 1994-08-05 | 1995-08-01 | Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5650404A (enExample) |
| EP (1) | EP0699440B1 (enExample) |
| KR (1) | KR960006915A (enExample) |
| AT (1) | ATE173626T1 (enExample) |
| CA (1) | CA2152693A1 (enExample) |
| DE (1) | DE69506197T2 (enExample) |
| ES (1) | ES2124477T3 (enExample) |
| TW (1) | TW317500B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| RU2232758C2 (ru) * | 1998-09-23 | 2004-07-20 | Рисерч Дивелопмент Фаундейшн | Токоферолы, токотриенолы и другие производные хромана и боковых цепей и способы лечения с их использованием |
| AU2001236805B2 (en) * | 2000-02-11 | 2005-07-14 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| WO2002026238A1 (en) * | 2000-09-26 | 2002-04-04 | Vital Health Sciences Pty Ltd. | Phosphate derivative supplements |
| AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| JP4745608B2 (ja) | 2001-07-27 | 2011-08-10 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 電子伝達剤のリン酸誘導体を用いた皮膚治療 |
| US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| ATE495730T1 (de) | 2004-03-03 | 2011-02-15 | Vital Health Sciences Pty Ltd | Alkaloid-formulierungen |
| EP2548581A3 (en) | 2005-06-17 | 2013-02-20 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| BRPI0621081A2 (pt) * | 2005-12-23 | 2011-11-29 | Vital Health Sciences Pty Ltd | método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos |
| ES2999020T3 (en) | 2010-02-05 | 2025-02-24 | Phosphagenics Ltd | Carrier comprising non-neutralised tocopheryl phosphate |
| SG184181A1 (en) | 2010-03-30 | 2012-10-30 | Phosphagenics Ltd | Transdermal delivery patch |
| RU2425669C1 (ru) * | 2010-04-13 | 2011-08-10 | Общество С Ограниченной Ответственностью "Гамаветфарм" | Средство для профилактики и лечения острого и хронического панкреатита |
| EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINOCHINOLINE AS A KINASEHEMMER |
| CN108601732A (zh) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | 药物制剂 |
| KR102647670B1 (ko) | 2016-12-21 | 2024-03-15 | 아베초 바이오테크놀로지 리미티드 | 방법 |
| WO2021062347A1 (en) * | 2019-09-27 | 2021-04-01 | Duke University | Compositions and methods for the prevention and treatment of pancreatitis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59219295A (ja) * | 1983-05-30 | 1984-12-10 | Senjiyu Seiyaku Kk | リン酸ジエステルまたはその塩およびそれらの製造法 |
| JPS62145019A (ja) * | 1985-12-19 | 1987-06-29 | Senjiyu Seiyaku Kk | 抗炎症剤 |
| JPS62205091A (ja) * | 1986-03-04 | 1987-09-09 | Senjiyu Seiyaku Kk | 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤 |
| JP2526059B2 (ja) * | 1987-04-28 | 1996-08-21 | 千寿製薬株式会社 | 抗潰瘍剤 |
| PH25859A (en) * | 1988-01-11 | 1991-12-02 | Takeda Chemical Industries Ltd | Composition for treatment of ischemic disorder |
| JP2854631B2 (ja) * | 1989-11-21 | 1999-02-03 | 千寿製薬株式会社 | 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤 |
-
1995
- 1995-06-27 CA CA002152693A patent/CA2152693A1/en not_active Abandoned
- 1995-06-28 TW TW084106619A patent/TW317500B/zh active
- 1995-07-18 US US08/503,722 patent/US5650404A/en not_active Expired - Fee Related
- 1995-08-01 ES ES95112104T patent/ES2124477T3/es not_active Expired - Lifetime
- 1995-08-01 DE DE69506197T patent/DE69506197T2/de not_active Expired - Fee Related
- 1995-08-01 EP EP95112104A patent/EP0699440B1/en not_active Expired - Lifetime
- 1995-08-01 AT AT95112104T patent/ATE173626T1/de not_active IP Right Cessation
- 1995-08-05 KR KR1019950024260A patent/KR960006915A/ko not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69506197D1 (de) | 1999-01-07 |
| EP0699440B1 (en) | 1998-11-25 |
| EP0699440A1 (en) | 1996-03-06 |
| US5650404A (en) | 1997-07-22 |
| ES2124477T3 (es) | 1999-02-01 |
| TW317500B (enExample) | 1997-10-11 |
| KR960006915A (ko) | 1996-03-22 |
| CA2152693A1 (en) | 1996-02-06 |
| DE69506197T2 (de) | 1999-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE173626T1 (de) | Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis | |
| DE69512925D1 (de) | Ortho-substituierte aromatische ether und ihre verwendung in schmerzstillenden pharmazeutischen zusammensetzungen | |
| MY117896A (en) | Quinazoline derivatives | |
| IL120584A (en) | 1,2-diphenylpyrrole derivatives, use thereof for the manufacture of a medicament and pharmaceutical compositions containing the same | |
| TWI255807B (en) | Therapeutic agents | |
| BG104561A (en) | Aryl fused azapolycyclic compounds | |
| ATE253918T1 (de) | Verwendung von hymenialdisin und dessen derivaten zur herstellung therapeutischer mittel | |
| ATE523194T1 (de) | Bis(thiohydrazidamide) in kombination mit taxol für die behandlung von krebs | |
| ATE206926T1 (de) | Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne | |
| ATE121939T1 (de) | Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion. | |
| PT781766E (pt) | Derivado heterociclico e medicamento | |
| ATE141508T1 (de) | Zusammensetzung zur förderung des lipidmetabolismus | |
| MX9804226A (es) | Derivados novedosos de 2,3,5-trimetil-4-hidroxianilida, su preparacion y su aplicacion de terapeutica. | |
| DE69428325D1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| ATE170852T1 (de) | Benzolsulfonamid-derivate zur behandlung der blaseninstabilität | |
| ATE156359T1 (de) | Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis | |
| BG104983A (en) | Aryl fused azapolycyclic compounds | |
| FI935800A0 (fi) | Antidepressiva och mot Parkisons sjukdom verksamma foereningar | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| DE69805305D1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| DE69837334D1 (de) | Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69518159D1 (de) | Mittel zur vorsorge und heilung von typ i allergischen krankheiten | |
| HUP0001773A2 (hu) | Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP9900668A2 (hu) | Szulfamidsavszármazékok, N-acil-szulfonamidok és szulfonil-karbamát-származékok alkalmazása lipoproteinszintet csökkentő gyógyászati készítmények előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |